Acadia Healthcare (NASDAQ:ACHC) Sees Large Volume Increase

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares saw unusually-high trading volume on Monday . Approximately 760,466 shares were traded during trading, a decline of 9% from the previous session’s volume of 836,102 shares.The stock last traded at $60.03 and had previously closed at $63.28.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Monday, August 19th. Barclays decreased their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $86.67.

Acadia Healthcare Trading Down 4.5 %

The firm has a market cap of $5.61 billion, a P/E ratio of -432.50, a P/E/G ratio of 2.19 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The firm has a 50 day simple moving average of $74.23 and a 200 day simple moving average of $71.62.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. During the same period in the prior year, the company posted $0.92 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently made changes to their positions in the stock. Blue Trust Inc. raised its holdings in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares in the last quarter. Mather Group LLC. purchased a new stake in shares of Acadia Healthcare during the 1st quarter valued at about $48,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Acadia Healthcare during the second quarter valued at approximately $59,000. nVerses Capital LLC purchased a new stake in Acadia Healthcare in the second quarter worth approximately $95,000. Finally, Innealta Capital LLC purchased a new stake in Acadia Healthcare during the 2nd quarter valued at $164,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.